Overview
Nathalie Vernaz practices practicing medicine in Geneve, Switzerland.
Her clinical expertise encompasses Agranulocytosis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Hepatitis C, and Hepatitis.
She is actively involved in clinical research, co-authoring 38 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nathalie Vernaz
Is Nathalie Vernaz a top-rated expert for Agranulocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Nathalie Vernaz is classified as an Experienced expert for Agranulocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nathalie Vernaz participate in research or clinical trials?
Yes. Nathalie Vernaz has published 38 articles and abstracts on conditions like Agranulocytosis. You can view a list of Nathalie Vernaz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AgranulocytosisMs. Vernaz isExperienced. Learn about Agranulocytosis.
- COVID-19Ms. Vernaz isExperienced. Learn about COVID-19.
- HepatitisMs. Vernaz isExperienced. Learn about Hepatitis.
- Hepatitis CMs. Vernaz isExperienced. Learn about Hepatitis C.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Severe Acute Respiratory Syndrome (SARS)